IPSEN PHARMA earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2021 | 2021-12-31 | €7760.00 | €7820.00 | 2026-06-19T16:33:25Z |
| 2020 | 2020-12-31 | €6570.00 | €6610.00 | 2026-06-19T16:33:25Z |
Revenue & profit (EUR)
| Concept | 2021 | 2020 |
|---|---|---|
| Revenue | €3.00B | €2.69B |
| Profit for the year | €646.7M | €548.9M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in IPSEN PHARMA's ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.